Follisave
Sector: Medical Device
Subsector: Treating Allopecia post chemotherapy
Geography: United States
Regulatory status: Class 1 submission
Follisave is Innovative medical device, designed to prevent chemotherapy induced alopecia (loss of hair). The company is developing a propriety patent-protected technology that will potentially protect 100% of patients from Chemotherapy-Induced Alopecia with no side effects.